-
Something wrong with this record ?
Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats
L. Kopkan, Z. Husková, Z. Vaňourková, M. Thumová, P. Škaroupková, J. Malý, H.J. Kramer, P. Dvořák, L. Červenka
Language English Country United States
Document type Research Support, Non-U.S. Gov't
- MeSH
- Acetophenones pharmacology MeSH
- Analysis of Variance MeSH
- Angiotensin II analysis physiology blood urine MeSH
- Antioxidants pharmacology MeSH
- Time Factors MeSH
- Cyclic N-Oxides pharmacology MeSH
- Dinoprost analogs & derivatives urine MeSH
- Hypertension complications physiopathology prevention & control MeSH
- Cardiomegaly complications prevention & control MeSH
- Blood Pressure MeSH
- Rats MeSH
- Kidney chemistry MeSH
- Malondialdehyde analysis MeSH
- Disease Models, Animal MeSH
- Myocardium chemistry MeSH
- Random Allocation MeSH
- Kidney Diseases complications prevention & control MeSH
- Oxidative Stress physiology MeSH
- Rats, Sprague-Dawley MeSH
- Rats, Transgenic MeSH
- Proteinuria MeSH
- Renin genetics MeSH
- Free Radical Scavengers pharmacology MeSH
- Spin Labels MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
- 000
- 03950naa 2200709 a 4500
- 001
- bmc11022998
- 003
- CZ-PrNML
- 005
- 20121114111735.0
- 008
- 110801s2009 xxu e Eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kopkan, Libor $7 xx0107287
- 245 10
- $a Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats / $c L. Kopkan, Z. Husková, Z. Vaňourková, M. Thumová, P. Škaroupková, J. Malý, H.J. Kramer, P. Dvořák, L. Červenka
- 314 __
- $a Department for Experimental Medicine, Institute for Clinical and Experimental Medicine, 1958/9 Videnska, CZ-140 21 Prague 4, Czech Republic.
- 520 9_
- $a Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a acetofenony $x farmakologie $7 D000098
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a angiotensin II $x analýza $x fyziologie $x krev $x moč $7 D000804
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a kardiomegalie $x komplikace $x prevence a kontrola $7 D006332
- 650 _2
- $a cyklické N-oxidy $x farmakologie $7 D003497
- 650 _2
- $a dinoprost $x analogy a deriváty $x moč $7 D015237
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a scavengery volných radikálů $x farmakologie $7 D016166
- 650 _2
- $a hypertenze $x komplikace $x patofyziologie $x prevence a kontrola $7 D006973
- 650 _2
- $a ledviny $x chemie $7 D007668
- 650 _2
- $a nemoci ledvin $x komplikace $x prevence a kontrola $7 D007674
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a malondialdehyd $x analýza $7 D008315
- 650 _2
- $a myokard $x chemie $7 D009206
- 650 _2
- $a oxidační stres $x fyziologie $7 D018384
- 650 _2
- $a proteinurie $7 D011507
- 650 _2
- $a náhodné rozdělení $7 D011897
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a potkani transgenní $7 D055647
- 650 _2
- $a renin $x genetika $7 D012083
- 650 _2
- $a spinové značení $7 D013113
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Husková, Zuzana, $d 1978- $7 xx0074206
- 700 1_
- $a Vaňourková, Zdeňka, $d 1973- $7 xx0074217
- 700 1#
- $a Thumová, Monika. $7 _AN037603
- 700 1_
- $a Škaroupková, Petra $7 xx0117683
- 700 1_
- $a Malý, Jan, $d 1943-2021 $7 nlk19990073523
- 700 1_
- $a Kramer, Herbert J. $7 xx0085908
- 700 1#
- $a Dvořák, Pavel. $7 xx0114163
- 700 1_
- $a Červenka, Luděk, $d 1967- $7 xx0037105
- 773 0_
- $t Vascular Pharmacology $w MED00008593 $g Roč. 51, č. 2-3 (2009), s. 175-181 $x 1537-1891
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110802094606 $b ABA008
- 991 __
- $a 20121114111750 $b ABA008
- 999 __
- $a ok $b bmc $g 881854 $s 732927
- BAS __
- $a 3
- BMC __
- $a 2009 $b 51 $c 2-3 $d 175-181 $m Vascular pharmacology $n Vascul Pharmacol $i 1537-1891 $x MED00008593
- LZP __
- $a 2011-4B09/jvme